Klin Farmakol Farm. 2011;25(3):126-130
Elderly patients represent a special group of population regarding the occurrence of adverse drug reactions. The adverse drug reactions
often remain unrecognised due to their non-characteristic symptoms and polymorbidity of elderly patients. In case of manifestation of
adverse drug reaction sometimes additional medication is added instead of adjustment of the dose of drug or its withdrawal. Anticholinergic
effects of medications represent a typical example of such often unrecognised adverse drug reactions. These drugs may cause
peripheral adverse drug reactions, e.g. dry mouth, constipation, urinary retention, tachycardia, mydriasis, inability to accommodate,
increased intraocular pressure or decreased secretion of sweat glands. Anticholinergic effects of medications on the central nervous
system may be a cause of sedation, worsening of cognitive functions or delirium. Many drugs show anticholinergic properties, however
in most cases these effects are not responsible for the mechanism of therapeutic action (e.g. amitriptyline, clozapine). The appropriate
identification of drugs with anticholinergic effects represents the basic condition for the reduction of anticholinergic burden of elderly
patients. There are several laboratory in vitro methods. The most important limitation of these methods is a complicated interpretation
of their results in clinical practice. The lists of drugs with anticholinergic properties represent a tool easily applicable in daily clinical
practice. The creation of such lists is based on the consensus of experts who take into consideration the literature data on individual
drugs as well as their own clinical experience. The aim of our article was to introduce the topic of anticholinergic effects of drugs. The
stress is put on the consequences of their manifestation as adverse drug reactions. The opportunities of identification of medications
with anticholinergic properties are described.
Published: December 1, 2011 Show citation